Tissue protection by anti-ischemic drugs

Area of Science:

• Physiology
• Pathology
• Pharmacology

Background:

• Ischemia followed by reperfusion causes microvascular disturbances, including no-reflow and leukocyte adhesion (reflow-paradox).
• These disturbances impair endothelial barrier function, leading to cellular and organ dysfunction.
• Therapeutic strategies must address both ischemic insult and reperfusion-induced microvascular damage.

Purpose of the Study:

• To investigate therapeutic strategies for preventing microvascular failure after ischemia/reperfusion.
• To evaluate interventions targeting both ischemic insult and reperfusion injury.
• To understand the mode of action of different therapeutic strategies in microcirculation models.

Main Methods:

• Utilized microcirculation models in hamsters and mice for chronic visualization.
• Studied striated muscle and skin microcirculation.
• Investigated various therapeutic strategies to protect tissues from post-ischemic microvascular disturbances.

Main Results:

• Demonstrated the effectiveness of specific therapeutic strategies in mitigating microvascular disturbances.
• Provided insights into the mechanisms underlying the protective effects of interventions.
• Highlighted the importance of addressing both phases of ischemia/reperfusion injury.

Conclusions:

• Therapeutic interventions can successfully prevent or reduce post-ischemic microvascular disturbances.
• Understanding the mode of action is crucial for developing effective treatments.
• Protecting microvascular integrity is key to preventing organ dysfunction following ischemia/reperfusion.